Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. BROKER RATINGS: Johnson Matthey and Meggitt receive upgrades

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Johnson Matthey and Meggitt receive upgrades

Fri, 30th Apr 2021 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

HSBC RAISES JOHNSON MATTHEY TO 'BUY' ('HOLD') - TARGET 3,750 (2,850) PENCE

----------

CITIGROUP RAISES WEIR GROUP PRICE TARGET TO 2,100 (1,900) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY CUTS RECKITT BENCKISER PRICE TARGET TO 7,300 (7,900) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 10,400 (9,600) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES STANDARD CHARTERED PRICE TARGET TO 630 (550) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES STANDARD CHARTERED PRICE TARGET TO 730 (690) PENCE - 'BUY'

----------

BERENBERG RAISES NATWEST PRICE TARGET TO 230 (200) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS NATWEST PRICE TARGET TO 295 (300) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES NATWEST PRICE TARGET TO 250 (245) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES LLOYDS PRICE TARGET TO 55 (47) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES LLOYDS PRICE TARGET TO 54 (50) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,200 (1,150) PENCE - 'SELL'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,510 (1,550) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FLUTTER PRICE TARGET TO 16,285 (15,485) PENCE - 'HOLD'

----------

JPMORGAN CUTS FLUTTER PRICE TARGET TO 15,970 (16,233) PENCE - 'NEUTRAL'

----------

HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 330 (290) PENCE - 'BUY'

----------

HSBC RAISES AVIVA PRICE TARGET TO 420 (390) PENCE - 'HOLD'

----------

BERENBERG RAISES SMITH & NEPHEW PRICE TARGET TO 2,020 (1,985) PENCE - 'BUY'

----------

BARCLAYS RAISES SMITH & NEPHEW PRICE TARGET TO 1,800 (1,750) PENCE - 'OVERWEIGHT'

----------

SOCGEN RAISES BAE SYSTEMS PRICE TARGET TO 606 (580) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES ST JAMES'S PLACE TARGET TO 1,300 (1,250) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,925 (2,920) PENCE - 'SELL'

----------

BARCLAYS RAISES SCHRODERS PRICE TARGET TO 3,550 (3,430) PENCE - 'EQUAL WEIGHT'

----------

GOLDMAN SACHS RAISES UNILEVER PRICE TARGET TO 4,850 (4,800) PENCE - 'BUY'

----------

JEFFERIES RAISES UNILEVER PRICE TARGET TO 4,700 (4,550) PENCE - 'BUY'

----------

JEFFERIES RAISES ROYAL DUTCH SHELL PRICE TARGET TO 1,930 (1,890) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES ROYAL DUTCH SHELL B PRICE TARGET TO 2,100 (2,000) PENCE - 'BUY'

----------

RBC CUTS GLENCORE PRICE TARGET TO 360 (370) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES INFORMA PRICE TARGET TO 670 (650) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

SOCGEN RAISES MEGGITT TO 'HOLD' ('SELL') - TARGET 499 (418) PENCE

----------

GOLDMAN SACHS CUTS MEGGITT PRICE TARGET TO 436 (457) PENCE - 'NEUTRAL'

----------

BANK OF AMERICA CUTS MEGGITT PRICE TARGET TO 550 (560) PENCE - 'BUY'

----------

CITIGROUP RAISES COMPUTACENTER PRICE TARGET TO 2,985 (2,600) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES ELEMENTIS PRICE TARGET TO 148 (136) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES 888 HOLDINGS PRICE TARGET TO 460 (420) PENCE - 'BUY'

----------

BARCLAYS CUTS SSP GROUP PRICE TARGET TO 370 (420) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES CONVATEC PRICE TARGET TO 260 (250) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES WH SMITH PRICE TARGET TO 2,200 (1,535) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 590 (515) PENCE - 'OUTPERFORM'

----------

LIBERUM CUTS TRAVIS PERKINS PRICE TARGET TO 1,791 (1,900) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES HSS HIRE PRICE TARGET TO 21 (12) PENCE - 'HOLD'

----------

BERENBERG RAISES CVS GROUP PRICE TARGET TO 2,400 (2,200) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 2,750 (2,400) PENCE - 'OUTPERFORM'

----------

HSBC RAISES KINGSPAN GROUP PRICE TARGET TO 79 (66) EUR - 'HOLD'

----------

BARCLAYS RAISES KERRY GROUP PRICE TARGET TO 131 (130) EUR - 'OVERWEIGHT'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
5678910111213

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.